Sandbox Rim: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 32: Line 32:
{{Family tree | | | B01 | | B02 | | B01= Infective endocarditis| B02= Aortic dissection}}
{{Family tree | | | B01 | | B02 | | B01= Infective endocarditis| B02= Aortic dissection}}
{{Family tree | | | |!| | | |!| | | | | | | }}
{{Family tree | | | |!| | | |!| | | | | | | }}
{{Family tree | | | C01 | | C02 | | C01= Does the patient have AR related heart failure symptoms?| C02= Emergent surgery}}
{{Family tree | | | C01 | | C02 | | C01= Does the patient have AR related heart failure symptoms?| C02= Emergent surgery<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = http://circ.ahajournals.org/content/121/13/e266.full | url = http://circ.ahajournals.org/content/121/13/e266.full | publisher =  | date =  | accessdate = }}</ref>
}}
{{Family tree | |,|-|^|-|.| | | | | | | | | }}
{{Family tree | |,|-|^|-|.| | | | | | | | | }}
{{Family tree | D01 | | D02 | | | | D01= Yes| D02= No}}
{{Family tree | D01 | | D02 | | | | D01= Yes| D02= No}}

Revision as of 15:51, 21 July 2014

Indications for Aortic Valve Replacement

Shown below is an algorithm depicting the indications for aortic valve replacement (AVR) in chronic aortic regurgitation.

Abbreviations: LVEF: left ventricular ejection fraction; LVEDD: left ventricular end diastolic diameter; LVESV: left ventricular end systolic diameter

 
 
 
 
 
 
 
 
 
 
 
 
 
 
What is the severity of the aortic regurgitation?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Severe regurgitation

❑ Vena contracta >0.6 cm
❑ Doppler jet width ≥ 65% of LVOT
❑ Regurgitant volume ≥60 mL/beat
❑ Regurgitant fraction ≥50%
❑ Effective regurgitant orifice ≥ 0.30 cm²
❑ Holodiastolic flow reversal in the proximal abdominal aorta
Left ventricle dilatation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Progressive regurgitation (Stage B)

❑ Vena contracta <0.6 cm
❑ Regurgitant volume <60 mL/beat
❑ Regurgitant fraction <50%
❑ Effective regurgitant orifice <0.30 cm²
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is the patient symptomatic?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Is the patient undergoing
another surgery?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
(Stage D)
 
 
 
 
 
 
 
 
 
No
(Stage C)
 
 
 
 
 
 
 
 
 
No
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ LVEF<50%
(Stage C2)
 
❑ The patient is undergoing another surgery
 
LVEF ≥ 50%
AND
❑ LVESD > 50mm
(Stage C2)
 
LVEF ≥ 50%
AND
❑ LVEDD > 65mm
AND
❑ Low surgical risk
 
LVEF ≥ 50%
AND
❑ LVESD ≤ 50mm
AND
❑ LVEDD ≤ 65mm
 
Monitor the patient periodically
❑ Control hypertension preferably with
❑ Dihydropyridine CCB, or
ACE inhibitors or ARBs

(Class I; Level of Evidence: B) ❑ Perform a periodic echocardiogram (Class I; Level of Evidence:B)

❑ Every 3 -5 years for mild regurgitation
❑ Every 1 - 2 years for moderate regurgitation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AVR (Class I)
 
AVR (Class I)
 
AVR (Class I)
 
AVR (Class IIa)
 
AVR (Class IIb)
 
Monitor the patient periodically
 
 
 
 
 
AVR (Class IIa)


Acute AR

 
 
 
 
What is the cause of acute AR?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infective endocarditis
 
Aortic dissection
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have AR related heart failure symptoms?
 
Emergent surgery[1]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule for early aortic valve replacement (Class I, level of evidence B)[1][2]
Click here for more details
 
Administer antibiotics
Follow up the patient
Click here for more details
 
 
 
  1. 1.0 1.1 "http://circ.ahajournals.org/content/121/13/e266.full". External link in |title= (help)
  2. Baddour, LM.; Wilson, WR.; Bayer, AS.; Fowler, VG.; Bolger, AF.; Levison, ME.; Ferrieri, P.; Gerber, MA.; Tani, LY. (2005). "Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America". Circulation. 111 (23): e394–434. doi:10.1161/CIRCULATIONAHA.105.165564. PMID 15956145. Unknown parameter |month= ignored (help)